GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
115 hedge funds and large institutions have $123M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+12
Holders Change %
+11.65%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
32
Reduced
30
Closed
24
Calls
$550K
Puts
$341K
Net Calls
+$209K
Net Calls Change
-$537K
Top Buyers
| 1 |
WP
1
Woodline Partners
San Francisco,
California
|
$5.59M |
| 2 |
2
Renaissance Technologies
New York
|
$3.51M |
| 3 |
3
Millennium Management
New York
|
$9.08M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$5.4M |
| 5 |
5
D.E. Shaw & Co
New York
|
$2.41M |
